Rui Shi

Rui Shi

Auto-generated profile, based on publicly available information

Rui Shi

State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong SAR 999077, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2022 in Science Advances
Verified
Journal Article
Open access
RSRui Shi
Rui Shi
PPPeichen Pan
Peichen Pan
RLRui Lv
Rui Lv
CMChongqing Ma
Chongqing Ma
EWEnhui Wu
Enhui Wu
JLJian Liu
Jian Liu
Malignant tumors will become vulnerable if their uncontrolled biosynthesis and energy consumption engaged in metabolic reprogramming can be cut off. Here, we report finding a glycolytic inhibitor targeting glioblastoma with graphite dots–assisted laser desorption/ionization mass spectrometry as an integrated drug screening and pharmacokinetic platform (GLMSD). We have performed high-throughput virtual screening to narrow an initial library of 240,000 compounds down to the docking of 40 compounds and identified five previously unknown chemical scaffolds as promising hexokinase-2 inhibitors. The best inhibitor (Compd 27) can regulate the reprogrammed metabolic pathway in U87 glioma cells (median inhibitory concentration ~ 11.3 μM) for tumor suppression. Highly effective therapy against glioblastoma has been demonstrated in both subcutaneous and orthotopic brain tumors by synergizing Compd 27 and temozolomide. Our glycolytic inhibitor discovery can inspire personalized medicine targeting reprogrammed metabolisms of malignant tumors. GLMSD enables large, high-quality data for next-generation artificial intelligence–aided drug development.

21 October 2022 in Small
Verified
Journal Article
Open access
RSRui Shi
Rui Shi
ZDZiliang Dong
Ziliang Dong
CMChongqing Ma
Chongqing Ma
RWRenfei Wu
Renfei Wu
RLRui Lv
Rui Lv
JLJian Liu
Jian Liu
Extracellular outer‐membrane vesicles (OMVs) are attractive for use as drug nanocarriers, because of their high biocompatibility and ability to enter cells. However, widespread use is hampered by low yields. Here, a high‐yield method for magnetic harvesting of OMVs fromEscherichia coliis described. To this end,E. coliare grown in the presence of magnetic iron‐oxide nanoparticles (MNPs). Uptake of MNPs byE. coliis low and does not increase secretion of OMVs. Uptake of MNPs can be enhanced through PEGylation of MNPs.E. coligrowth in the presence of PEGylated MNPs increases bacterial MNP‐uptake and OMV‐secretion, accompanied by upregulation of genes involved in OMV‐secretion. OMVs containing MNPs can be magnetically harvested at 60‐fold higher yields than achieved by ultracentrifugation. Functionally, magnetically‐harvested OMVs and OMVs harvested by ultracentrifugation are both taken‐up in similar numbers by bacteria. Uniquely, in an applied magnetic field, magnetically‐harvested OMVs with MNPs accumulate over the entire depth of an infectious biofilm. OMVs harvested by ultracentrifugation without MNPs only accumulate near the biofilm surface. In conclusion, PEGylation of MNPs is essential for their uptake inE. coliand yields magnetic OMVs allowing high‐yield magnetic‐harvesting. Moreover, magnetic OMVs can be magnetically targeted to a cargo delivery site in the human body.

29 July 2025 in Analytical Chemistry
Verified
Journal Article
Open access
YCYanyan Chen
Yanyan Chen
RSRui Shi
Rui Shi
JWJianing Wang
Jianing Wang
CXChengyi Xie
Chengyi Xie
YSYuanyuan Song
Yuanyuan Song
ZCZongwei Cai
Zongwei Cai
High-resolution mass spectrometry imaging (MSI) plays a vital role in lipidomics, yet challenges persist in analyzing lipids at the single-cell level due to limitations in spatial resolution and lipid coverage. While existing strategies based on a single matrix application step for dual-polarity provide high lipid coverage from the same sample and enable easy sample preparation, matrix depletion limits their spatial resolution to 10 μm, preventing their application to single-cell imaging. Here, we present a single-cell/subcellular resolution strategy for dual-polarity matrix-assisted laser desorption and ionization mass spectrometry imaging (MALDI-MSI) that eliminates the need for matrix reapplication. This approach achieves 5 μm spatial resolution while maintaining lipid coverage comparable to multistep single-cell imaging methods. This is enabled by a fine-tuned matrix deposition technique that fully utilizes the high sensitivity of N-(1-naphthyl)-ethylenediamine dihydrochloride (NEDC) in dual polarities and optimized acquisition conditions, allowing single-deposition workflows without the need for washing, repreparation, or image recalibration. This single-cell resolution MALDI-MSI strategy successfully imaged a broader range of lipid species with distinctive spatial detail in mouse kidney tissue and lung carcinoma cells (A549). Using spatial probabilistic latent semantic analysis (PLSA), we identified three distinct lipid distribution patterns within a single-cell population in both polarities, and histogram analysis revealed substantial cell-to-cell lipidomic heterogeneity. This strategy overcomes limitations of traditional dual-polarity MSI and provides a powerful tool for advancing cellular lipidomics, elucidating disease mechanisms, and investigating environmental toxicology.

21 May 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
RWRenfei Wu
Renfei Wu
TGTianjin Ge
Tianjin Ge
TYTianrong Yu
Tianrong Yu
QSQiaolan Shi
Qiaolan Shi
RSRui Shi
Rui Shi
HMHenny C. Van der Mei
Henny C. Van der Mei
The era of relying on antibiotics for curing bacterial infections is rapidly approaching an end, necessitating development of non-antibiotic-based infection-control strategies. Dispersal of infectious biofilms is a potential strategy but yields dispersed bacteria in blood that may cause sepsis. We report a bromide-loaded, core-shell ZnO2-nanoparticle/Ce-based metal-organic framework (ZnO2@CeMOF/Br) of which the ZnO2 core degrades at pH ≤ 6.5, leaving the MOF's Ce node intact. ZnO2-core degradation initially generates a nonradical, relatively stable, low-oxidative hydrogen peroxide that can cleave matrix DNA causing dispersal of Staphylococcus aureus biofilms and reacts with bromide ions to form transient hypobromous acid. Hypobromous acid modulates macrophage polarization toward an M1-like phenotype to clear dispersed bacteria from blood. Subsequently the Ce3+/Ce4+ redox couple forming the Ce node acts as an electron shuttle upon oxidation/reduction to faciltate two catalytic reactions, maintaining hydrolysis of phosphodiester bonds and associated cleavage of matrix DNA as well as modulation of macrophage polarization. Neither growth of tissue cells or macrophages nor hemolysis are negatively affected by exposure to ZnO2@CeMOF/Br nanocatalysts at a ZnO2 nanoparticle over CeMOFs weight ratio ≤ 1.2, up until CeMOF concentrations less than at least 180 μg/mL. Under biosafe, low-turnover catalytic conditions, irrigation of infected wounds in diabetic mice with ZnO2@CeMOF/Br nanocatalysts (90 μg/mL) results in 100% survival, fast recovery of healthy body temperature and weight, lower numbers of CFUs in blood and wound and organ tissues, and macrophage polarization toward an M1-like phenotype, demonstrating potential of ZnO2@CeMOF/Br nanocatalysts for non-antibiotic-based infection control.

8 May 2026 in Science Advances
Verified
Journal Article
Open access
CWChen Wang
Chen Wang
RSRui Shi
Rui Shi
Anatolii AbalymovAnatolii Abalymov
Anatolii Abalymov
HBHao Bao
Hao Bao
Thomas Ka Yam LamThomas Ka Yam Lam
Thomas Ka Yam Lam
VVVenkatasubramanian K. Venkiteswaran
Venkatasubramanian K. Venkiteswaran
Real-time biomarker sensing and molecular sampling in the stomach can transform how gastrointestinal disorders are diagnosed and managed—yet integrating both capabilities into a single ingestible platform remains a formidable challenge. Existing devices often struggle with size constraints, limited functionality, and the mechanical mismatch between soft, biocompatible materials and rigid electronics. Here, we present SeroTab, an electronics-free soft robotic minitablet that combines real-time pH sensing with on-demand gastric fluid sampling in vivo. Inspired by the gliding motion of penguins through viscous environments, SeroTab features a magnetically actuated, curvature-adaptive body that enables autonomous navigation through complex anatomical geometries to specific gastric regions. Upon reaching its target, a shape memory polymer actuator—triggered wirelessly via radio frequency heating—draws gastric fluid into an internal reservoir (up to 35 microliters). A pH-sensitive hydrogel within the chamber, embedded with biocompatible metal disks, enables ultrasound-based pH readout across a physiologically relevant range (pH 2 to 7) and preserves the sample for untargeted metabolomic profiling. In vivo studies in animal models demonstrate SeroTab’s ability to detect pharmacologically induced pH changes (ΔpH = 4, from 2 to 6) and metabolic shifts (42 detected metabolites) following omeprazole administration. By uniting soft robotics, responsive materials, and wireless actuation, SeroTab paves the way for minimally invasive, outpatient-compatible diagnostics that can advance early screening and streamline clinical decision-making.